Clinical Trial Update: Evaluating Neostigmine Effect on Reducing Gastric Residual Volume as Compared With Metoclopramide and Ondansetron [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neostigmine versus metoclopramide and ondansetron for reducing gastric residual volume in delayed gastric emptying.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Gastric Emptying

Drugs mentioned

• Metoclopramide (metoclopramide)
• Neostigmine (neostigmine)
• Ondansetron (ondansetron)

Snippet

Sponsor: Tanta University | Conditions: Delayed Gastric Emptying | Phase 2 | Status: COMPLETED